PharmaPendium supports drug safety and efficacy decisions for better drug outcomes

• ヒトへの適用のための強力な前臨床と臨床のデータとツールを見つける

• 自社の新薬候補と同じ作用機序を持つ、承認薬および販売中止薬に対するベンチマーク

• 予測対象：

  • 有害事象

  • 動物モデル

  • 薬物間相互作用

  • 臨床評価項目

  • 安全性マージン

• より多くのものを見つけ、予測すればするほど、動物実験の必要性は減っていきます。

• 動画視聴 新しいタブ／ウィンドウで開く

• すべての規制当局への申請を成功させるための迅速かつ効果的な戦略の予測

• PharmaPendiumを使用した薬事サイクルの最小化および承認取得失敗の回避

• 過去の規制当局への申請に関する情報の検索および前例からの情報による当局要件の予測

Developed in collaboration with Pfizer, Tox Navigator includes toxicity data from regulatory documents and scientific articles.

Supporting the 3Rs and patient safety assessment, the Tox Navigator helps you:

• Convert animal doses to human equivalent doses

• Leverage existing data to reduce number of animal studies and design more efficient studies

• Investigate adverse drug reactions across different species

• Integrate in silico models and other non-animal testing methods

• Optimize research efforts by focusing on candidates with favorable safety profiles

Advance your research with Elsevier’s PharmaPendium and a portfolio of solutions for pharmaceutical R&D.

Innovate with confidence, supported by:

• Trusted quality information from regulatory data to peer-reviewed scientific literature

• Innovative technology that powers data transformation and analytical and predictive tools

• Domain and data science expertise to solve complex problems with data solutions for R&D

Information integrity is essential to your progress. Discover trusted data and tools that deliver critical insights.

Let's shape progress together.